Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Subcutaneous Pembrolizumab and the Coordination of Neoadjuvant Immunotherapy in Head and Neck Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer.
10.1056/nejmoa2415434 · 2025 · External reference
Subcutaneous versus intravenous pembrolizumab in combination with chemotherapy for metastatic non–small cell lung cancer: the phase II 3475A-D77 trial.
10.1016/j.annonc.2025.03.012 · 2025 · External reference
Geographic variation in the utilization of cancer care from subspecialized medical oncologists in the United States, 2008 to 2020.
10.7326/annals-25-00102 · 2025 · External reference
Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update.
10.1200/jco.21.01440 · 2021 · External reference
A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease.
10.1016/j.ejca.2024.114148 · 2024 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
